Column Group Management LP, 10% Owner, Ten Percent Owner Other, Director at NGM BIOPHARMACEUTICALS INC (NGM), bought 8,210 shares at $17.99 ($148K) on 2020-07-28, disclosed to the SEC on 2020-07-30.
Open-market purchase of $148k NGM by 10% Owner, Ten Percent Owner Other, Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade C.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $17.99 | 4,105 | $74K | 50.0% |
| 2 | $17.99 | 4,105 | $74K | 50.0% |
| Total | $17.99 avg | 8,210 | $148K | 100% |
| Filing → |
| NGM | BUY | 2019-11-06 | $202K | — | Filing → |
| NGM | BUY | 2019-08-05 | $61K | — | Filing → |
| NGM | BUY | 2019-04-10 | $30.2M | — | Filing → |